Shoaib Faruqi
Objective Assessment of Cough: An Early Marker of Response to Biological Therapies in Asthma?
Faruqi, Shoaib; Sykes, Dominic L.; Crooks, Michael G.; Brindle, Kayleigh; Thompson, Joanne; Morice, Alyn H.
Authors
Dominic L. Sykes
Prof Michael Crooks m.g.crooks@hull.ac.uk
Professor of Respiratory Medicine
Kayleigh Brindle
Joanne Thompson
Professor Alyn Morice A.H.Morice@hull.ac.uk
Foundation Chair and Professor of Respiratory Medicine
Abstract
© 2020, Springer Science+Business Media, LLC, part of Springer Nature. Cough is an important symptom of asthma. The objective assessment of chronic cough has been enhanced by the development of ambulatory cough monitoring systems. Mepolizumab has been demonstrated to reduce exacerbations in eosinophilic asthmatics long-term. We evaluate the utility of objective cough count as an outcome measure in severe eosinophilic asthma treated with mepolizumab. Consecutive, consenting patients initiated on treatment with mepolizumab had a 24-h cough count recorded at baseline; this was repeated at 1, 3 and 6 months. Asthma control questionnaire (ACQ) scores and exacerbation frequency were also recorded. The mean 24-h cough count in 11 subjects (8 females, mean age 53.6 years) was 172.4 at baseline; at 1, 3 and 6 months following initiation of treatment this decreased to 101.4, 92 and 70.8, respectively (p < 0.02). Significant improvements were also observed in mean ACQ score (3–1.6, p < 0.01) and exacerbation frequency (5.5 per year – 1.3, p < 0.01). Objective cough measurement could be used as an early, precise and clinically relevant endpoint in assessing response to asthma therapy.
Citation
Faruqi, S., Sykes, D. L., Crooks, M. G., Brindle, K., Thompson, J., & Morice, A. H. (2020). Objective Assessment of Cough: An Early Marker of Response to Biological Therapies in Asthma?. Lung, 198(5), 767-770. https://doi.org/10.1007/s00408-020-00391-w
Journal Article Type | Article |
---|---|
Acceptance Date | Aug 27, 2020 |
Online Publication Date | Sep 10, 2020 |
Publication Date | 2020-10 |
Deposit Date | May 10, 2022 |
Journal | Lung |
Print ISSN | 0341-2040 |
Publisher | Springer Verlag |
Peer Reviewed | Peer Reviewed |
Volume | 198 |
Issue | 5 |
Pages | 767-770 |
DOI | https://doi.org/10.1007/s00408-020-00391-w |
Public URL | https://hull-repository.worktribe.com/output/3618073 |
You might also like
TRPA1 agonists evoke coughing in guinea pig and human volunteers
(2009)
Journal Article
Cough hypersensitivity syndrome: A distinct clinical entity
(2010)
Journal Article
Chronic cough and esomeprazole: A double-blind placebo-controlled parallel study
(2011)
Journal Article
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search